The Hidden Cost of Contraception: Unveiling the Truth Behind Paragard

PUBLISHED:

See more TechGraph stories in your search results.
Google Add TechGraph on Google

Paragard, one of the leading copper IUDs in the USA, has become a symbol of contraceptive freedom for many women. It offers a viable alternative to daily pills or invasive procedures because of its long-term efficacy and low maintenance. 

Yet, as technology progresses and consumer awareness grows, uncertainties surrounding the safety of IUDs keep surfacing. Concerns, including extended pain post-implantation, complications during removal, and heightened bleeding, are prompting inquiries into the well-being of women’s reproductive health.

- Advertisement -

Whether you are exploring Paragard for the first time or have already used it, this blog post is for you. Join us as we highlight the issues behind the apparent convenience, revealing the diverse aspects of Paragard’s story.

Freedom from the Daily Grind: The Enduring Appeal of Paragard

Sold under the brand ParaGard by Teva Women’s Health Pharmaceuticals, the copper IUD gained FDA approval in 1984 and has been accessible in the United States since 1988.  As of now, 10.4% of women aged 15–49 are utilizing long-acting reversible contraception, such as intrauterine devices or contraceptive implants.

Unlike the recurring commitment required by oral contraceptives or the irreversible nature of sterilization, Paragard offers a unique appeal: long-lasting, low-maintenance prevention of undesired pregnancies. This unique mixture strikes a chord with American women, like you, who are looking for contraceptive measures that grant them empowerment and freedom.

The key strength of Paragard lies in its powerful efficacy. A one-time, in-office insertion provides up to 12 years of continuous protection with a 99.2% success rate during the first year and reaching an astounding level of 99.8% throughout its entire lifetime.

This major difference from user-dependent methods such as pills and patches, which have higher failure rates, puts Paragard in a favorable position. In addition to providing reliable protection, it also frees you from the anxieties and risks that come with contraceptive lapses.

Beyond its efficacy, Paragard stands out for its minimal user responsibility. Once implanted, it eliminates the daily task of remembering and taking pills or the monthly ritual of ring insertion and extraction.

Also, Paragard has been found to cause minimal hormonal issues. This appeals to women who are seeking contraception without potential side effects like mood swings, irregular weight changes, or breast softness.

It also offers future flexibility to accommodate a woman’s wish to bear kid(s). In contrast to permanent sterilization procedures, Paragard remains reversible.

If necessary, the device can be extracted, enabling women to restore their natural fertility and plan for pregnancy at their preferred time. This characteristic can be especially important for younger women who desire extended protection while keeping the door open for future motherhood.

Navigating the Complexities and Potential Downsides of Paragard

While Paragard has revolutionized the landscape of reproductive health for numerous women, its lure is by no means without a dark side.

Many women have claimed that the device has a design fault and that there have been instances of it breaking down during its extraction. If you or someone you’re acquainted with has experienced health issues due to using the Paragard IUD, you have the right to initiate a Paragard lawsuit.

These claims against a device that was FDA-approved and is widely available in the market demand transparent conversations and well-informed choices. This segment will shed light on three such concerns:

Copper Toxicity: A Double-Edged Sword?

The central issue with the use of this device is its copper composition. Copper repels sperm and its presence in the IUD creates a toxic environment where these cells cannot thrive. 

- Advertisement -

Multiple research studies have indicated that the copper from the IUD gets released as ions into the uterus. A theory suggests that during menstruation, these ions enter the bloodstream, a notion backed by the observation of allergic episodes coinciding with menstrual bleeding.

However, the incidence of severe allergies, due to the release of copper in the blood, has not been widely reported. More research is being carried out in this domain as only minimal evidence suggests negative health outcomes.

Even though the data is inconclusive, it is your discretion whether to use Paragard or not.  Moreover, you should be extremely careful and informed in your decision if you have pre-existing disorders.

For instance, if you are suffering from a genetic condition called Wilson’s disease, where your body is unable to flush out extra copper, you need to be extra cautious while using Paragard. 

Pelvic Inflammatory Disease: A Looming Threat?

Some studies suggest a possible link between Paragard and pelvic inflammatory disease (PID) that impacts reproductive organs. This domain is still under comprehensive research. However, it has been found that the overall risk of infection is reduced after the first three months. 

It is very important to remember that PID can also occur without the use of Paragard; here, the main cause of the disease is sexually transmitted infections.

Continuous communication with healthcare professionals regarding a sexual history along with keeping up regular gynecological examinations is essential to proactive risk reductions.

Device Migration: A Journey Unforeseen?

Women have been using Paragard for years now. So, it is known that the implant process is tried and tested and has a high success rate. 

But, there have been cases where the implanted device has moved. The chances of this happening are higher in the initial few months. An intrauterine device (IUD) might shift under the following circumstances:

  • You experience vigorous uterine contractions during your menstrual period.
  • Your uterine cavity is small.
  • Your uterus has a noticeable tilt.

As per TorHoerman Law, those impacted may have to undergo invasive procedures like hysteroscopy to remove the shattered fragments within the uterus. Additionally, there is a risk of these pieces migrating to other parts of the body.

It is crucial to discuss these risks with your healthcare provider before proceeding with the implant.

The Intangible Toll: Emotions and Finances

Although the physical risks posed by Paragard are severe, you cannot overlook the toll they can take on your mental health. Implanting a foreign medical device in your body is not child’s play. 

You are bound to be concerned about risks like copper toxicity or device migration. Imagine your mental ordeal if you start questioning every twinge, every ache, wondering if it’s just another harmless pain or something more.

Moreover, IUD implants are not always cost-effective. Even after getting the implant, you need to be ready for unforeseen medical costs. Complications or corrective surgeries can be expensive. Procedures like pelvic ultrasounds or even removal and reinsertion can affect your budget.

However, it’s important to note that you are not alone in this journey. Online forums like Scarleteen can be invaluable to put your mind at rest about your Paragard experience, both medically and emotionally.

Stay ahead of the curve, every day.

A daily briefing covering news, interviews, and the trends driving the world forward. Curated for readers who want news, not noise.

We don’t spam! Read our privacy policy for more info.

- Advertisement -
Krishna Mali
Krishna Mali
Founder & Group Editor of TechGraph.

Latest Stories

White Label Crypto Exchange vs Building From Scratch: Guide for Fintech Companies

Compare white label crypto exchanges with custom development across cost, control, compliance, maintenance, and long-term product ownership for fintech.

InspeCity Space Laboratories Appoints Rajeev Gambhir as Executive Vice President

Rajeev Gambhir will lead strategic partnerships and institutional engagement as InspeCity scales its space technology business.

Vingo Snaps $1.2 Mn in Seed Round Led by IndiaQuotient

The fresh capital will support product development, trust infrastructure, and user acquisition as the startup expands its marketplace.

Hero Enterprise, Cap Alpha Ventures Lead ₹65 Crore Series A in Vaaree

The investment will support Vaaree’s plans to improve deliveries and build new AI-powered home styling tools for its online marketplace.

Nebius Appoints Former Square Executive Lindsey Irvine as CMO

Former Square executive Lindsey Irvine has been named Chief Marketing Officer at Nebius, where she will oversee the AI cloud company’s global marketing efforts.

QubeHealth-Pay, Petos Partners to Expand Pet Healthcare Payments

The integration brings QubeHealth-Pay’s healthcare payment infrastructure to the pet insurance platform, with the companies targeting over ₹50 crore in pet healthcare payments within 18 months.

Gaurs Group to Launch Luxury Residential Project Gaur Alaris on Yamuna Expressway

Gaurs Group expects its latest luxury housing project near the Noida International Airport to generate nearly ₹1,900 crore in sales.

Related Articles

White Label Crypto Exchange vs Building From Scratch: Guide for Fintech Companies

Compare white label crypto exchanges with custom development across cost, control, compliance, maintenance, and long-term product ownership for fintech.

InspeCity Space Laboratories Appoints Rajeev Gambhir as Executive Vice President

Rajeev Gambhir will lead strategic partnerships and institutional engagement as InspeCity scales its space technology business.

Vingo Snaps $1.2 Mn in Seed Round Led by IndiaQuotient

The fresh capital will support product development, trust infrastructure, and user acquisition as the startup expands its marketplace.

Hero Enterprise, Cap Alpha Ventures Lead ₹65 Crore Series A in Vaaree

The investment will support Vaaree’s plans to improve deliveries and build new AI-powered home styling tools for its online marketplace.

QubeHealth-Pay, Petos Partners to Expand Pet Healthcare Payments

The integration brings QubeHealth-Pay’s healthcare payment infrastructure to the pet insurance platform, with the companies targeting over ₹50 crore in pet healthcare payments within 18 months.

Gaurs Group to Launch Luxury Residential Project Gaur Alaris on Yamuna Expressway

Gaurs Group expects its latest luxury housing project near the Noida International Airport to generate nearly ₹1,900 crore in sales.

ProMobi Rolls Out New Scalefusion Update for Enterprise IT Teams

The latest Scalefusion update reflects how enterprise IT priorities are shifting from managing devices to securing users, identities and endpoints through a single platform.

InvestValue Launches ₹20 Crore ESOP for More Than 75% of Employees

The Fintech company is broadening employee ownership beyond leadership with a ₹20 crore ESOP programme covering more than three-quarters of its workforce.

Remsons Industries Appoints Rahul Prabhakar Desai as CEO

Rahul Prabhakar Desai has been appointed CEO of Remsons Industries, succeeding Amit Srivastava as the automotive components manufacturer advances its planned leadership transition.

InvestValue Launches ₹20 Crore ESOP for More Than 75% of Employees

The Fintech company is broadening employee ownership beyond leadership with a ₹20 crore ESOP programme covering more than three-quarters of its workforce.

Remsons Industries Appoints Rahul Prabhakar Desai as CEO

Rahul Prabhakar Desai has been appointed CEO of Remsons Industries, succeeding Amit Srivastava as the automotive components manufacturer advances its planned leadership transition.

PayMe CEO Mahesh Shukla on Where Loans Against Mutual Funds Fit in India’s Credit Market

Mahesh Shukla, Founder & CEO of PayMe, outlines how India’s expanding mutual fund investor base is creating new opportunities for asset-backed lending without disrupting long-term wealth creation.

The Privacy Imperative: Judge India’s Abhishek Agarwal on Modernising Enterprise Infrastructure

The Judge Group’s Abhishek Agarwal discusses why data privacy is becoming a strategic business priority and how it is shaping enterprise technology and digital transformation strategies.

Beyond the Profile Picture: FRND CPO Harshvardhan Chhangani on Building Social Discovery for Bharat

FRND Co-founder and CPO Harshvardhan Chhangani discusses why voice-first interactions and AI-powered identity are redefining social discovery for users beyond India’s metro markets.

Nebius Appoints Former Square Executive Lindsey Irvine as CMO

Former Square executive Lindsey Irvine has been named Chief Marketing Officer at Nebius, where she will oversee the AI cloud company’s global marketing efforts.

PayMe CEO Mahesh Shukla on Where Loans Against Mutual Funds Fit in India’s Credit Market

Mahesh Shukla, Founder & CEO of PayMe, outlines how India’s expanding mutual fund investor base is creating new opportunities for asset-backed lending without disrupting long-term wealth creation.

The Privacy Imperative: Judge India’s Abhishek Agarwal on Modernising Enterprise Infrastructure

The Judge Group’s Abhishek Agarwal discusses why data privacy is becoming a strategic business priority and how it is shaping enterprise technology and digital transformation strategies.

Human-in-the-Loop: Why AI in Education Still Needs the Professor

Generative AI is rapidly entering classrooms, boardrooms, and training programs. Yet a critical question...

Human-in-the-Loop: Why AI in Education Still Needs the Professor

Generative AI is rapidly entering classrooms, boardrooms, and training programs. Yet a critical question...

A Beginner’s Guide to Annual Auto Maintenance

Annual auto maintenance helps keep your vehicle reliable, safe, and ready for everyday driving....

Grading in the AI Era: AssessPrep’s Karan Gupta on Building Teacher-Led Assessment Models for Schools

As AI reshapes education, AssessPrep Co-Founder Karan Gupta discusses why teachers must remain at the centre of grading decisions and how this can support assessment without replacing educator judgement.

The Governance Gap in the Age of Autonomous AI

As AI systems evolve from assistants into autonomous decision-makers, governance is becoming as critical as the technology itself. The article explores why accountability, transparency and human oversight will shape the next phase of enterprise AI adoption.